188 Chapter 8 6.0. 2021. Arlington, MA: Statistical Innovations Inc 24. Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using ‘ggplot2’. R package version 0.4.9. 2021. 25. Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York, 2016. 26. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285-292. 27. Fowler VG, Jr., Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163(17):2066-2072. 28. Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, et al. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallelgroup, randomised, controlled, non-inferiority trial. Lancet Infect Dis. 2024. 29. Cooper G, Dolby HW, Berry K, Russell CD. Eligibility of patients with Staphylococcus aureus bacteraemia for early oral switch. Lancet Infect Dis. 2024. 30. Hendriks MMC, Schweren KSA, Kleij A, et al. Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: A multicenter retrospective cohort study. Clin Infect Dis. 2024. 31. Anpalagan K, Dotel R, MacFadden DR, et al. Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial. Clin Infect Dis. 2024. 32. Fowler VG, Jr., Das AF, Lipka-Diamond J, et al. Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT). Clin Infect Dis. 2024.
RkJQdWJsaXNoZXIy MTk4NDMw